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Disección endoscópica de la submucosa
gástrica en neoplasia intraepitelial de bajo
grado
Endoscopic  mucosal  resection  (EMR)  was  developed  for  the
purpose  of  preserving  complete  gastrointestinal  function
after  the  resection  of  a  lesion  limited  to  the  mucosa  of  the
digestive  tract,  as  well  as  for  obtaining  larger  specimens
that  would  enable  a  precise  histopathologic  diagnosis.1
In  Japan,  different  techniques  were  developed  for  EMR
that  were  divided  into  three  modalities:  EMR  with  a
double-channel  endoscope,  aspiration  EMR,  and  endoscopic
submucosal  dissection  (ESD).2
EMR  is  typically  used  for  removing  lesions  smaller  than
2  cm  or  removal  by  sections  in  large  lesions.  ESD  was  devel-
oped  for  en  bloc  resection  (EBR),  regardless  of  the  size  of
the  lesion.3
There  are  important  ethical  considerations  in  the  for-
mation  process  of  this  new  technique.  Up  to  the  present,
the  results  have  been  promising.  Nevertheless,  the  lack  of
training  centers,  together  with  potential  complications  (per-
foration,  bleeding),  has  limited  the  expansion  of  its  use  in
Mexico.
The  basic  requirements  suggested  for  surgeons  and  gas-
troenterologists  that  wish  to  perform  this  technique  are:  a)
certiﬁcation  in  gastrointestinal  endoscopy,  b)  training  in  the
use  of  the  devices,  techniques,  and  technologies  for  iden-
tifying  and  treating  premalignant  conditions  and  incipient
cancer  in  the  esophagus,  stomach,  small  bowel,  and  colon,
c)  experience  in  hemostasis,  and  d)  training  in  ESD.  A  pro-
posed  training  model  encompasses:  a  ﬁrst  phase  in  which  the
procedure  performed  by  qualiﬁed  specialists  is  observed;
a  second  phase  of  practice  using  inanimate  and  animate
models;  a  third  phase  of  training  in  humans  under  the
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upervision  of  qualiﬁed  specialists;  and  ﬁnally,  performing
he  procedure  in  humans.4
The  aim  of  this  letter  was  to  present  the  case  of  a
atient  with  a  histologic  diagnosis  of  low-grade  intraepithe-
ial  gastric  neoplasia  (low-grade  dysplasia)  and  to  provide  a
iterature-based  analysis  of  the  role  of  endoscopic  resection
n  this  premalignant  condition.
An  81-year-old  woman  sought  medical  attention  com-
laining  of  weight  loss  of  10  kg  in  3  months.  As  part  of
er  evaluation  protocol  an  abdominal  computerized  axial
omography  scan  with  double  contrast  was  taken  that
eported  probable  thickening  of  the  esophageal  mucosa
0.8  mm).  Upper  gastrointestinal  endoscopy  was  performed,
dentifying  erosive  gastropathy  in  the  fundus  and  a  slightly
levated  non-polypoid  superﬁcial  prepyloric  lesion  (Paris
lassiﬁcation  0-IIa)  that  measured  2  cm  in  diameter.  Digital
hromoendoscopy  showed  follicular  changes  in  the  mucosa
ith  no  vascular  irregularities.
The  histopathologic  report  of  the  biopsies  described  low-
rade  intraepithelial  neoplasia  /  dysplasia  (World  Health
rganization  Classiﬁcation)  in  the  antral  mucosa  (Fig.  1)  and
ild  focal  atrophy  that  was  negative  for  Helicobacter  pylori.
reoperative  laboratory  study  results  were  within  normal
arameters.For  the  purpose  of  obtaining  a  precise  histologic  diag-
osis  of  a  well-deﬁned  lesion,  2 endoscopists  skilled  in  the
SD  technique  (MR  and  JH)  performed  the  procedure  after
eceiving  the  informed  consent  of  the  patient.
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Figure  2  Blue  arrow:  Low-grade  gastric  mucosal  dysplasia.
Loss  of  polarity  of  the  basal  nuclei  showing  a  pseudostratiﬁed
pattern  with  nuclear  pleomorphism  and  hyperchromasia  (hema-
toxylin  and  eosin  stain)  Red  arrow:  Gastric  gland.  Intestinal
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An  Olympus  GIF-180  gastroscope  was  employed.  Indigo
armine  at  5%  was  applied  to  deﬁne  the  margins  of  the  lesion
y  contrast.  An  endoscopic  Flex  Knife®  was  used  to  mark
he  circumference  of  the  lesion  with  monopolar  energy  (cut
0/coagulation  30);  the  submucosa  was  inﬁltrated  with  3
c  of  saline  solution  at  0.9%  and  1.5  cc  of  hyaluronic  acid
sing  an  injector  (Olympus  NM-200U0423).  The  circumfer-
ntial  cut  of  the  lesion  was  made  with  the  endoscopic  Flex
nife  and  the  submucosa  was  dissected  with  the  IT  Knife2®,
ntil  the  lesion  was  completely  resected  (Fig.  2).
Hemostasis  was  veriﬁed  and  the  operative  ﬁeld  was  irri-
ated  with  saline  solution  after  resection.  Surgery  duration
as  65  minutes  and  there  were  no  complications.  The  pre-
ious  diagnosis  was  conﬁrmed  by  histopathology.
Intraepithelial  neoplasia  of  the  gastric  mucosa  is  the
enultimate  stage  of  carcinogenesis.  It  is  deﬁned  as  a  non-
nvasive  gastric  neoplasia,  characterized  by  cellular  atypia
nd  by  abnormal  differentiation  and  disorganization  of  the
landular  architecture.5
The  correct  diagnosis  and  grade  classiﬁcation  of  intraep-
thelial  neoplasia  is  crucial  because  it  predicts  the  risk  for
alignant  transformation.  You  et  al.  conducted  a  prospec-
ive  study  on  546  patients  with  dysplasia  during  the  5-year
ollow-up  and  found  that  gastric  cancer  progression  was  0.6%
er  year  for  low-grade  dysplasia  and  1.4%  for  high-grade
ysplasia.6
De  Vries  et  al.  included  7,616  patients  with  low-grade
ysplasia  and  562  with  high-grade  dysplasia  during  a  5-year
ollow-up.  The  annual  incidence  of  gastric  cancer  was  0.6%
or  low-grade  dysplasia  and  6%  for  high-grade  dysplasia.7
The  European  Society  of  Gastrointestinal  Endoscopy
ESGE)  recommends  endoscopic  resection  for  the  purpose
f  obtaining  a  precise  histologic  diagnosis  in  patients  pre-
enting  with  low-grade  dysplasia  in  whom  a  well  deﬁned
esion  has  been  identiﬁed  during  the  endoscopy.8 Kim  et  al.
valuated  the  discrepancy  in  the  diagnosis  of  low-grade  dys-
lastic  lesions  obtained  with  biopsy  forceps  or  EMR  in  273
atients  and  found  histologic  concordance  in  73%;  19%  of  the
R
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ases  presented  with  higher-grade  dysplastic  lesions,  and
ven  adenocarcinoma,  after  resection.9
In  a  case  series  of  41  patients,  Hull  et  al.  found  discord-
nce  in  39%  of  the  cases  regarding  diagnoses  obtained  with
iopsy  forceps  and  EMR.  The  authors  concluded  that  EMR
as  superior  in  diagnosing  superﬁcial  lesions,  particularly
hose  that  are  larger  than  10  mm.10
Further  studies  are  needed  that  evaluate  the  risk  /  bene-
t  of  endoscopic  resection  of  the  gastric  mucosa  in  patients
iagnosed  with  low-grade  intraepithelial  neoplasia.
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An infrequent cause of
iron-deﬁciency anemia: Blue
rubber bleb nevus syndrome
Una causa infrecuente de anemia ferropénica:
blue rubber bleb nevus syndrome
Iron-deﬁciency  anemia  can  be  caused  by  occult  bleeding  of
the  digestive  tract  secondary  to  diverse  lesions  of  different
prevalence  and  severity.1 Among  them  are  those  of  vascular
origin,  such  as  blue  rubber  bleb  nevus  syndrome  (BRBNS),
also  known  as  Bean  syndrome,  initially  described  by  Gas-
coyen  in  1860.  In  1958  Bean  associated  the  lesions  of  the
skin  with  those  of  the  gastrointestinal  tract,  and  since  then
the  syndrome  bears  his  name.2
A  45-year-old  woman  was  referred  to  our  hospital  center
to  study  her  iron-deﬁciency  anemia.  Her  personal  and  family
medical  histories  were  unremarkable.  Hematocrit  was  27%,
hemoglobin  9.0  g/dl,  white  blood  cell  count  7,500/mm3,
serum  iron  60  g/dl,  coagulogram  was  normal,  and  sero-
logy  for  celiac  disease  was  negative.  The  medical  history
was  taken  and  the  patient  did  not  complain  of  symptoms  or
ﬁndings  that  could  be  linked  to  anemia  or  gastrointestinal
bleeding.  The  physical  examination  revealed  the  presence
of  vascular  lesions  on  the  feet  and  abdomen  (Fig.  1).
The  lesions  were  round,  bluish,  rubbery,  and  nonpainful
and  had  a  diameter  that  varied  from  1  to  3  cm.  One  of  the
lesions  deformed  a  foot.  Upper  and  lower  gastrointestinal
video  endoscopy  was  performed,  displaying  a  lesion  on  the
anterior  surface  of  the  pyloric  antrum  that  measured  2  cm
in  diameter;  it  was  bluish  and  rounded  and  had  a  soft  con-
sistency  (Fig.  2A).
Three  similar  lesions  were  observed  on  the  colon
(Fig.  2B).  There  were  no  signs  of  bleeding  and  the  abdominal
ultrasound  was  normal.  Given  the  cutaneous  and  gastroin-
testinal  lesions,  BRBNS  was  diagnosed  and  it  was  assumed
to  be  responsible  for  the  anemia,  once  urologic  and  gyne-
cologic  bleeding  was  ruled  out.  The  patient  agreed  with  the
recommendation  not  to  evaluate  the  small  bowel,  given  that
she  did  not  present  with  symptoms.  Oral  iron  replacement
BRBNS  is  a  rare  syndrome  that  combines  the  presence
of  cutaneous  and  visceral  venous  malformations  that  are
typically  small,  circumscribed,  and  multifocal.  Even  though
the  disease  appears  sporadically  in  the  majority  of  reported
cases,  some  have  a  dominant  autosomal  component  related
to  a  mutation  of  chromosome  9p.3 The  epidemiology  and
natural  history  of  BRBNS  is  not  well  known.  Due  to  its
rareness,  emphasized  by  all  authors,  there  are  no  ﬁgures
related  to  prevalence,  the  incidence  of  bleeding,  or  mor-
tality.  There  are  thought  to  be  about  150  communicated
cases  worldwide.4 The  digestive  tract  is  frequently  com-
promised  by  multiple  papilliform  bluish  lesions.  The  small
bowel  is  the  most  common  location,  followed  by  the  colon,
but  there  can  also  be  lesions  at  the  mouth  of  the  anus.3 In
general,  they  are  present  from  birth  and  their  appearance
in  adulthood  is  less  likely.2,3 The  majority  of  the  cases  man-
ifest  as  occult  bleeding.  In  the  largest  case  series  to  date,
Fishman  et  al.  conducted  their  study  on  32  patients  from  a
referral  center;  22  of  them  presented  with  minimal  bleed-
ing  and  10  had  severe  bleeding.2 Rare  complications  such
as  intussusception,  volvulus,  infarct,  and  obstruction  have
been  reported.5 The  cutaneous  lesions  are  generally  small,
measuring  less  than  2  cm;  their  color  ranges  from  blue  to
purple  and  they  rarely  bleed  spontaneously.  Other  uncom-
mon  locations  are:  the  brain,  eyes,  oral  cavity,  thyroid,
lungs,  pericardium,  pleura,  spleen,  liver,  kidneys,  bladder,
and  muscle  and  skeletal  system.4,6 The  extradigestive  and
extracutaneous  lesions  can  produce  epistaxis,  hemoptysis,was  begun  and  her  anemia  was  corrected.  The  patient  is
presently  in  stable  condition.
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